Durvalumab vs Imatinib

## Durvalumab vs Imatinib: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Imatinib**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Imatinib**: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Imatinib — 18 hours.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Imatinib — C29H31N7O.

**Molecular Weight**: Durvalumab — N/A; Imatinib — 493.6030 g/mol.

**Type**: Durvalumab — Antibody; Imatinib — Small molecule.